UPMC/Pitt Health Sciences Newsroom

Tiny Antibody Component Highly Effective Against COVID-19

A molecular discovery by University of Pittsburgh infectious disease scientists is being turned into a drug to treat and prevent COVID-19.

James E. Taylor Ph.D., UPMC chief diversity, inclusion and talent management officer, and John Galley, UPMC senior vice president and chief human resources officer will speak at the 14th annual Diversity MBA National Virtual Elite Business Leaders Conference.

A blood protein test could detect the severity of head trauma in under 15 minutes, according to research published recently in the Journal of Neurotrauma.

2018's overdose death decline coincides with Chinese drug regulations, rather than US domestic policy efforts, Pitt Public Health finds.

News Releases

Thursday, September 17, 2020
UPMC Hillman Offers New Immunotherapy for MCL

Thursday, September 17, 2020
Rapid Blood Test Could Detect Brain Injury in Minutes

Thursday, September 17, 2020
UPMC Leaders to Speak at Diversity MBA Leadership Conference

Wednesday, September 16, 2020
Pollution and Stroke Risk in People with Atrial Fibrillation

Wednesday, September 16, 2020
Potent Drug Supply Drop Likely Behind 2018 OD Death Downturn

See Full Listing of News Releases »

In The News

Becker’s Hospital Review
UPMC taps life sciences leader as president of digital health, entrepreneurial efforts

The Allegheny Front
Study Finds Link Between Air Pollution And Risk Of Stroke For People With Afib

Philadelphia Inquirer
Gov. Wolf’s COVID-19 restrictions saved thousands of lives in Pennsylvania, Pitt researchers say

Williamsport Sun-Gazette
UPMC, University of Pittsburgh discover antibodies to help prevent, treat COVID-19

The Daily American
UPMC comments on treatments, vaccine timeline

See Full Listing of News Mentions »

Expert Spotlight

Samira Kiani, M.D., associate professor of pathology at Pitt, uses the latest gene editing tools to develop novel precision medicine therapies. Her lab recently published a paper in Nature Cell Biology demonstrating that CRISPR can not only be used to permanently edit the genome as part of gene therapy, but also temporarily suppress the immune response to allow viral vectors carrying gene therapy cargo to slip through undetected. This technology could make gene therapy more effective.